Latest Prescription Drugs news
Loss of Therapeutic Benefit Seen After Stopping Baricitinib in Type 1 Diabetes
posted September 29th
by modernClinician Editorial Team
by modernClinician Editorial Team
Antithymocyte Globulin Cuts Loss of β-Cell Function in Type 1 Diabetes
posted September 29th
by modernClinician Editorial Team
by modernClinician Editorial Team
FDA Grants Accelerated Approval for First Treatment for Barth Syndrome
posted September 25th
by modernClinician Editorial Team
by modernClinician Editorial Team
Oral Semaglutide Effective for Weight Loss in Overweight or Obesity
posted September 25th
by modernClinician Editorial Team
by modernClinician Editorial Team
Editor's Recommendations
Drug Interactions Reducing Contraceptive Effectiveness Common in Epilepsy .jpg)
Most Specialty Oral Anticancer Meds for Blood Cancers Are Initially Rejected by Insurers 
2018 to 2025 Saw Sharp Rise in Postpartum GLP-1 Receptor Agonist Use 
1 in 3 With Lupus Take Supplements, Medications With Potential for Interactions Related Articles
Holding DMARDs at Time of COVID-19 Vaccine Not Warranted in Those With Inflammatory Arthritis 
2013 to 2024 Saw Decrease in Benzodiazepine Prescribing 
Polypharmacy of Prescription Medications Increased for U.S. Older Adults 
GLP-1 Receptor Agonists, SGLT-2is Slow Renal Function Decline in T2D With Albuminuria Monthly Specialist Briefings
Stay Connected
